nephrotic syndrome
nephrotic syndrome
Explore linked clinical trials. Standard reference: MONDO:000537755 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Meal Macronutrients on Postprandial Lipids | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Insulin Resistance, Lipid Metabolism Disorders, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Skin Diseases, Metabolic, Skin and Connective Tissue Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, kidney disorder, lipodystrophy, metabolic disease, nephrosis, nephrotic syndrome, skin disorder, urinary system disorder | Not yet recruiting | Phase 2 | 2026-10-09 | NCT07313787 | |
| Immune System Related Kidney Disease | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-09-28 | NCT00001979 | |
| Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, proteinuria, urinary system disorder | Recruiting | Phase 2 | 2026-09-22 | NCT00977977 | |
| Belimumab With Rituximab for Primary Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Phase 2 | 2026-09-18 | NCT03949855 | |
| Super Chinese Nephrotic Syndrome Registration System (SUCCESS) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-09-15 | NCT03001934 | |
| Single-cell RNA Sequencing (scRNA-seq) to Investigate the Mechanisms Underlying the Induction of Regulatory T Cells in Patients With Extramembranous Glomerulonephritis Treated With Rituximab | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Not yet recruiting | Not applicable | 2026-09-10 | NCT07811557 | |
| Clinical Prediction Model for Disease Progression in Primary Membranous Nephropathy | Disease Attributes, Disease Progression, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Not yet recruiting | Not stated | 2026-09-02 | NCT07785739 | |
| Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Not yet recruiting | Phase 3 | 2026-08-14 | NCT07765914 | |
| Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Charcot-Marie-Tooth disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Primary Immunodeficiency Diseases, Skin Abnormalities, Skin and Connective Tissue Diseases, Urogenital Diseases, adrenal gland disorder, adrenocortical insufficiency, autoimmune disease, brain disorder, central nervous system disorder, central nervous system malformation, endocrine system disorder, hereditary disease, hereditary motor and sensory neuropathy, hypothyroidism, ichthyosis, immune system disorder, inborn error of immunity, inborn errors of metabolism, inherited neurodegenerative disorder, keratosis, kidney disorder, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nephrosis, nephrotic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, skin disorder, sphingolipidosis, thyroid gland disorder, urinary system disorder | Recruiting | Not stated | 2026-08-04 | NCT06669949 | |
| RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Multi-Drug Resistant Nephrotic Syndrome, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, nephritis, nephrosis, nephrotic syndrome, systemic lupus erythematosus, urinary system disorder | Not yet recruiting | Early phase 1 | 2026-06-29 | NCT07674147 | |
| Atacicept in Multiple Glomerular Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Phase 2 | 2026-06-26 | NCT06983028 | |
| From Immune System Damage to Podocyte Cell Damage: Prospective Database and Biological Collection of Patients (Children and Adults) With MGLS and HSFP | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-06-22 | NCT04174066 | |
| Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, chronic renal failure syndrome, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, kidney failure, minimal change disease, nephritis, nephrosis, nephrotic syndrome, proteinuria, urinary system disorder | Active, not recruiting | Not stated | 2026-06-11 | NCT02194582 | |
| NEPTUNE Match Study | Alport syndrome, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Skin and Connective Tissue Diseases, Urogenital Abnormalities, Urogenital Diseases, autoimmune disease, connective tissue disorder, focal segmental glomerulosclerosis, glomerulonephritis, hereditary nephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not applicable | 2026-06-10 | NCT04571658 | |
| Nephrotic Syndrome Study Network | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, macular corneal dystrophy, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-06-10 | NCT01209000 | |
| SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, kidney disorder, nephrosis, nephrotic syndrome, proteinuria, urinary system disorder | Recruiting | Phase 2 / Phase 3 | 2026-06-09 | NCT07214818 | |
| CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Multi-Drug Resistant Nephrotic Syndrome, Skin and Connective Tissue Diseases, Urogenital Diseases, autoimmune disease, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, nephritis, nephrosis, nephrotic syndrome, skin disorder, systemic sclerosis, urinary system disorder | Recruiting | Early phase 1 | 2026-05-14 | NCT07586267 | |
| REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Urogenital Diseases, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Active, not recruiting | Phase 3 | 2026-05-11 | NCT06635720 | |
| A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines | Chronic Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Malformations of Cortical Development, Group I, Neoplasms, Multiple Primary, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, central nervous system malformation, cerebral cortical dysplasia, chronic renal failure syndrome, hamartoma, hereditary disease, hereditary neoplastic syndrome, inherited neurodegenerative disorder, kidney disorder, kidney failure, neoplasm, nephrosis, nephrotic syndrome, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, proteinuria, tuberous sclerosis, urinary system disorder | Recruiting | Not applicable | 2026-05-01 | NCT07561957 | |
| Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Multi-Drug Resistant Nephrotic Syndrome, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, necrotizing vasculitis, nephritis, nephrosis, nephrotic syndrome, skin disorder, skin vascular disease, systemic sclerosis, urinary system disorder, vascular disorder, vasculitis | Recruiting | Early phase 1 | 2026-04-02 | NCT07507201 | |
| Multitarget Strategy for Primary Podocytopathies | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not applicable | 2026-03-27 | NCT06718894 | |
| An Outcome Analysis of Primary Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2026-03-23 | NCT06242327 | |
| CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Multi-Drug Resistant Nephrotic Syndrome, Skin and Connective Tissue Diseases, Urogenital Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, connective tissue disorder, glomerulonephritis, immune system disorder, kidney disorder, necrotizing vasculitis, nephritis, nephrosis, nephrotic syndrome, skin disorder, skin vascular disease, systemic sclerosis, urinary system disorder, vascular disorder, vasculitis | Recruiting | Phase 1 | 2026-02-03 | NCT07305116 | |
| Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome. | Edema, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nephrotic Syndrome, Minimal Change, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, autoimmune disease, disease, focal segmental glomerulosclerosis, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, minimal change disease, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Not stated | 2025-12-22 | NCT05505500 | |
| A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome | Childhood Idiopathic Nephrotic Syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Active, not recruiting | Phase 3 | 2025-12-15 | NCT05627557 |